EUVIMEDEUVIMED entdecken
CrossrefInfokarte

IS SARM – Selective Androgen Receptor Modulator: A Chance for Therapeutic Approach in Muscle-Wasting Chronic Conditions?

Alessandro Bartoli, Nicola Maffulli, Gabriella Oliva, Salvatore Ziello, Francesco Oliva

Muscles, Ligaments and Tendons Journal · 2024-06-30 · 14 (2)

DOI: 10.32098/mltj.02.2024.17 ↗
AbstractBibliografische Angaben

Abstract

Purpose of review. The purpose of this paper is to review the current concepts regard­ing a new-old pharmacological class, SARM (Selective Androgen Receptor Modula­tor). Especially how SARM can be beneficial in treatment of orthopedic disease. Materials and methods. Androgens (testosterone and dihydrotestosterone (DHT)) are the male sex hormones required for development of the male reproductive system and secondary sexual characteristics. SARMs due to ability to bind androgen receptor are excellent in treatment of various diseases. Discussion. Based on the published literature, a review has been carried out on SARM and its fields of application in the treatment of muscle wasting pathologies. Starting from the history of the SARMs, its role in prevention of muscle wasting, anabolic effects and side effects were addressed. Conclusions. Nonsteroidal SARMs are unique in their ability to bind the androgen receptor with high affinity and exhibit tissue selective activity. SARMs can be used to treat muscle wasting conditions, osteoporosis, frailty syndrome without unwanted side effects associated with androgens.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →